Successful treatment of pyogenic granulomas following gefitinib therapy with partial matricectomy and phenolization

Journal of Dermatological Treatment

Volumn 20, Issue 6, 2009, Pages 374-375

  Dika, Emi ^a   Balestri, Riccardo ^a   Vaccari, Sabina ^a   Alessandro Fanti, Pier ^a   Misciali, Cosimo ^a   Patrizi, Annalisa ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CLOBETASOL PROPIONATE; ERYTHROMYCIN; GEFITINIB; PSEUDOMONIC ACID;

AGED; CASE REPORT; DRUG WITHDRAWAL; ERYTHEMA; FEMALE; FOLLICULITIS; HUMAN; HUMAN TISSUE; INFLAMMATORY INFILTRATE; LETTER; LUNG CANCER; MATRICECTOMY; METASTASIS; PARONYCHIA; PHENOLIZATION; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; PYOGENIC GRANULOMA; SKIN BIOPSY; SKIN NODULE; SKIN SURGERY; TREATMENT OUTCOME;

AGED; ANTI-INFECTIVE AGENTS, LOCAL; ANTINEOPLASTIC AGENTS; FEMALE; GRANULOMA, PYOGENIC; HUMANS; LUNG NEOPLASMS; NAILS, INGROWN; PHENOL; QUINAZOLINES; TOES; TREATMENT OUTCOME;

EID: 72449151757     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.3109/09546630902773502     Document Type: Letter

References (6)

1. Guhl G, Gonzales-de Arriba A, Dauden E. Epidermal growth factor receptor inhibitors side effects. Actas Dermosifiliogr. 2006;97:296-310.
2. Graves JE, Jones BF, Lind AC, Heffernan MP. Nonscarring inflammatory alopecia associated with the epidermal growth factor receptor inhibitor gefitinib. J Am Acad Dermatol. 2006;55:349-353
3. High WA. Gefitinib: A case of pyogenic granuloma-like lesions of the nail. Arch Dermatol. 2006;142:939.
4. Piraccini BM, Iorizzo M, Starace M, Tosti A. Drug-induced nail disease. Dermatol Clin. 2006;24:387-391
5. Frantz S. Drug discovery: Playing dirty. Nature. 2005;437:942-943
6. Segaert S, Van Cutsem E. Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors. Ann Oncol. 2005;16:1425-1433